Search Results - "hepatocellular carcinoma"

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy by Mei J, Sun XQ, Lin WP, Li SH, Lu LH, Zou JW, Wei W, Guo RP

Connect to this object online.

Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature by Giuseppe Tarantino, Paolo Magistri, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto

Connect to this object online.

Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles by Bian Y, Guo D

Connect to this object online.

Uncovering essential anesthetics-induced exosomal miRNAs related to hepatocellular carcinoma progression: a bioinformatic investigation by Ning Huang, Jie Fang, Fang Du, Jichuan Zhou, Yuxin Li, Xiaoguang Zhang

Connect to this object online.

Effect of music therapy on postembolization syndrome in Thai patients with hepatocellular carcinoma: A quasi-experimental crossover study by Wassana Khuntee, Kanitha Hanprasitkam, Bualuang Sumdaengrit

Connect to this object online.

RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma by Hao Peng, Erwei Zhu, Jitao Wang, Jitao Wang, Xuanlong Du, Chonggao Wang, Meng Yang, Yewei Zhang

Connect to this object online.

Exposure to Cadmium Telluride Quantum Dots and Gene Expression Profile of Huh-7 Hepatocellular Carcinoma Cell Line by Hani Alothaid, Mashael R. Al-Anazi, Arwa A. Al-Qahtani, Dilek Colak, Azeez Yusuf, Mohammed S. Aldughaim, Ali M. Mahzari, Mahmoud M. Habibullah, Saud Alarifi, Saad Alkahtani, Ahmed A. Al-Qahtani

Connect to this object online.

A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma by Jianlin Zhu, Junxi Kuang, Yi Yang, Lei Zhang, Bo Leng, Risheng She, Ling Zou

Connect to this object online.

Serum microRNA 143 as a potential biomarker for the diagnosis of hepatitis C virus-related hepatocellular carcinoma by Ahmed M El-Gohary, Ahmed E Zeid, Mohamed E Ibrahim, Fatma I Dewedar, Essam A Elzoheiry

Connect to this object online.

Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis by Yuemin Nan, Department of Traditional & Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, 050051, China, Xianzhong Lu, Yue Zhang, Li Xie, Zhongyi Niu, Wen Chen

Connect to this object online.

Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association by Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi

Connect to this object online.

Tislelizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis by Zhiwei Zheng, Yuxuan Lin, Yuxuan Lin, Hongfu Cai

Connect to this object online.

Comprehensive Identification of Bridge Genes to Explain the Progression from Chronic Hepatitis B Virus Infection to Hepatocellular Carcinoma by Nong W, Ma L, Lan B, Liu N, Yang H, Lao X, Deng Q, Huang Z

Connect to this object online.

C-Type Lectin Receptors-Triggered Antifungal Immunity May Synergize with and Optimize the Effects of Immunotherapy in Hepatocellular Carcinoma by Xia J, Ding H, Liu S, An R, Shi X, Chen M, Ren H

Connect to this object online.

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab by Yong Tae Kim, Jina Kim, Jinsil Seong

Connect to this object online.

Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy by Wu M, Yang S, Feng X, Li C, Liu X, Zhang Z, Xiao Y, Liu C, Dong J

Connect to this object online.

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma by Liang Sun, Zhengyi Wu, Cairong Dong, Shian Yu, He Huang, Zhendong Chen, Zhipeng Wu, Xiangbao Yin

Connect to this object online.

Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma by Junfeng Ye, Ruoyan Zhang, Wengang Chai, Xiaohong Du

Connect to this object online.

An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma by Zhonghai Du, Xiuchen Han, Liping Zhu, Li Li, Leandro Castellano, Justin Stebbing, Ling Peng, Zhiqiang Wang

Connect to this object online.

The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications by Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis

Connect to this object online.